Jan Kaiserle

The completion of a rolling Biologics License Application (BLA) by Ultragenyx Pharmaceutical Inc. represents a potential turning point for individuals living with Glycogen Storage Disease Type Ia (GSDIa), a relentless genetic disorder. The submission to the U.S. Food and Drug Administration is for

A new frontier is opening in the fight against cancer and other complex diseases, one that moves beyond the conventional strategy of simply destroying malignant cells and toward the more sophisticated approach of actively reprogramming them. In a significant leap forward for protein therapy, an

Today we’re joined by Ivan Kairatov, a biopharma expert at the intersection of technology and healthcare innovation. He’s here to break down a groundbreaking global study that uses artificial intelligence to untangle the complex web of factors driving cancer survival rates across nearly every

Today, we have the privilege of speaking with Ivan Kairatov, a biopharma expert at the forefront of technological innovation in research and development. His work delves into one of the most exciting intersections in modern medicine: the use of artificial intelligence to accelerate the fight

Within the dense, jargon-filled lines of a patient's medical chart, the earliest signs of cognitive decline may be hiding in plain sight, often too subtle for even the most diligent clinician to detect during a routine appointment. These faint signals, scattered across years of notes, represent a

For the first time in over a quarter-century, projections indicate a monumental shift in a public health crisis that has disproportionately affected European women, as the relentless rise in lung cancer mortality is finally showing signs of stabilizing. This development suggests a critical turning

The foundational technologies that underpin modern medicine are undergoing a profound transformation, positioning the global cell culture consumables and equipment market for unprecedented expansion. Projections indicate that this critical sector, valued at US$ 13.06 billion in 2025, is on a

A single class of molecules exists at the very heart of cellular life, acting as both a catalyst for vibrant growth and a quiet harbinger of decline, a duality that has long puzzled the scientific community. These molecules, known as polyamines, are fundamental to the function of every living cell,

A multi-billion dollar investment in a single location can signal many things, but when a global healthcare leader repeatedly commits to the same state, it transforms from a business decision into a powerful statement about the future of American manufacturing. The recent groundbreaking for Johnson

For millions grappling with the profound and persistent darkness of major depression, the journey to find an effective treatment can be a long and disheartening road, but a landmark clinical trial has now provided powerful evidence that an implanted medical device offers substantial and lasting